Ameridose, LLC, Issues Voluntary Recall of All Products

NASHVILLE. – The Tennessee Department of Health has been notified that Ameridose, LLC, based in Westborough, Mass., has issued a voluntary recall of all unexpired products in circulation. At this time, TDH and the Food and Drug Administration are not aware of any health issues associated with any Ameridose products in Tennessee or elsewhere.

The FDA, in announcing the recall, indicated that health care providers do not need to follow up with patients who received Ameridose products, but that clinicians should stop using Ameridose products and return them to the firm. FDA’s news release on this recall is available online at www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm326361.htm.

Ameridose, LLC, is licensed in Tennessee as both a pharmacy and as a pharmacy manufacturer/wholesaler/distributor. The Massachusetts Board of Registration in Pharmacy stated Ameridose “voluntarily ceased all pharmacy operations and any dispensing, manufacturing or wholesale distribution of any products as of 3 p.m. on October 10, 2012.” To see the agreement, visit www.mass.gov/eohhs/docs/dph/quality/boards/pharmacy-ameridose-agreement-20121019.pdf.

Ameridose has provided information on the recall, including a complete list of products, online at www.ameridose.com.

The mission of the Tennessee Department of Health is to protect, promote and improve the health and prosperity of people in Tennessee. For more information about TDH services and programs, visit http://health.state.tn.us/.